ArticleOncotarget2016

Novel B55α-PP2A mutations in AML promote AKT T308 phosphorylation and sensitivity to AKT inhibitor-induced growth arrest.

Geoffrey Shouse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.